From: Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis
Characteristic | Academic biostatisticians | Consultant biostatisticians | Academic clinicians | Other stakeholders |
---|---|---|---|---|
Mean age | 47 | 45 | 49 | 52 |
Female, 21/53 (39.6%) | 3 (60) | 1 (17) | 5 (23) | 12 (60) |
Highest degree, 53 | ||||
MD or equivalent | 0 | 2 (33) | 20 (91) | 7 (35) |
PhD | 5 (100) | 4 (67) | 4 (18) | 12 (60) |
Primary work location, 52 | ||||
University/University hospital | 5 (100) | 1 (17) | 21 (96) | 3 (15) |
Community hospital | 0 | 0 | 0 | 0 |
Government (NIH or FDA) | 0 | 0 | 0 | 15 (75) |
Consulting firm | 4 (67) | 1 (5) | ||
Other | 0 | 0 | 0 | 2 (10) |